Factors Associated with Real-World Multitarget Stool DNA Test Adherence and Follow-up Colonoscopy Completion in a California Healthcare System
Background: Colorectal cancer (CRC) is highly treatable when diagnosed early, but screening benefit depends on completing both initial testing and follow-up colonoscopy (FU-CY) after a positive stool-based test. Objectives: As quality measurements increasingly emphasize FU-CY after positive noninvasive CRC screening results, this study evaluated factors associated with multitarget stool DNA (mt-sDNA) adherence and FU-CY completion within the Providence Healthcare System in California. Methods: This retrospective cohort study linked laboratory data from Abbott with administrative claims data from Komodo Health. The study population included mt-sDNA tests shipped to patients between July 2016 and June 2023. Adherence was defined as return of a completed test with a valid result within one year of shipment. Completion of FU-CY was defined as the first eligible colonoscopy claim occurring within 1 year of a positive mt-sDNA result. Multivariable logistic regression was used to identify factors associated with mt-sDNA adherence. Among test kits with a positive mt-sDNA finding, factors associated with time to FU-CY were evaluated using Cox proportional hazards regression. Results: Of 6191 mt-sDNA test kits, 4766 (77.0%) were completed within 1 year. Higher adjusted odds of adherence were observed among males, among patients with commercial, Medicare Advantage, or traditional Medicare insurance compared with Medi-Cal; among patients with prior mt-sDNA use; among gastroenterologist-ordered tests; and among those receiving full digital or SMS-only outreach. Among 560 patients with positive mt-sDNA results, who met the continuous enrollment requirement, 394 (70.4%) completed FU-CY within 1 year. Gastroenterologist-ordered tests were associated with shorter time to FU-CY completion (adjusted hazard ratio, 2.26; 95% CI, 1.31-3.88). Discussion: High mt-sDNA screening adherence and FU-CY completion were observed in this California-based Providence cohort, although adherence varied across patient and healthcare delivery characteristics. These results suggest that both demographic and healthcare delivery factors influence the effectiveness of screening programs. Conclusions: These findings suggest that modifiable healthcare delivery strategies, including digital reminders, and coordinated follow-up pathways, may support participation and diagnostic continuity in stool-based CRC screening programs.
Authors
- Gustavus Aranda
- Ruchira V. Mahashabde (ORCID: https://orcid.org/0000-0003-2448-1489)
- Jordan J. Karlitz (ORCID: https://orcid.org/0000-0001-5686-7365)
- Jeffrey Arroyo (ORCID: https://orcid.org/0009-0001-2022-6360)
- Jennifer Yi-Jiun Pan (ORCID: https://orcid.org/0000-0001-6713-6402)
- Mallik Greene (ORCID: https://orcid.org/0000-0001-9363-5483)
- Ora Gordon
Publication Details
- Journal
- Journal of health economics and outcomes research
- Published
- 2026-11-19
- DOI
- https://doi.org/10.36469/jheor.2026.172785
- Primary Topic
- Colorectal Cancer Screening and Detection
- Type
- article
- Field-Weighted Citation Impact
- 0.00